SRA's number for the day: 3,867,243
This article was originally published in SRA
Executive Summary
As of 31 December 2012, the EU's EudraVigilance database for collecting, managing and analyzing reports of suspected side effects to medicinal products held a total of 3,867,243 adverse reaction reports, referring to 2,224,670 individual cases1,2.
You may also be interested in...
European CHMP Opinions and MAA Updates
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
UK’s NICE Backs Two Microsphere Products For Liver Cancer But Says No To Another
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
New Evidence For Kisqali Secures Funding In England For Second-Line Use
The decision by health technology assessment body NICE on Novartis’s advanced breast cancer drug, Kisqali, contrasts sharply with its recommendation for another CDK4/6 inhibitor – Lilly’s Verzenios.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: